CorVel Corp. (CRVL)
NEUTRALFundamental
66
Preço
$69.93
Capitalização de Mercado
$3.61B
Parte 1 · Quanto vale a empresa
Visão Geral
CorVel Corporation provides workers' compensation, general and auto liability, and hospital bill auditing and payment integrity solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing; preferred provider management and reimbursement; retrospective utilization, facility claim, and professional review; pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions. In addition, it provides a range of patient management services, such as claims management customers, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company offers solutions to employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. CorVel Corporation was incorporated in 1987 and is based in Fort Worth, Texas.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
Balanço & Liquidez
Receita
$984M
Últimos 12 meses (até 30/06/2026)
Resultado Líquido
$115M
Últimos 12 meses (até 30/06/2026)
Fluxo de Caixa Livre
$110M
Capital Próprio Total
$394M
Passivo Total
$249M
Rácio de Liquidez
1.94
Cobertura de Juros
-
Dívida/EBITDA
0.15
Resultados Por Ação
Receita & Resultado Líquido
Fluxo de Caixa Livre
Decomposição dos Resultados
Demonstração histórica
Margens ao longo do tempo
A dívida ao longo do tempo
Quanto pesa a dívida
Grelha do crescimento
Crescimento — Receitas
Estimativa de Valor Justo
Valor Justo
$26.35
Preço Atual
$69.93
Margem de Segurança
-165.4%
Intervalo de Valor Justo
$21.89 - $30.80
Métodos de Estimativa
Métricas de Avaliação
Rácio P/E
31.66
ROE
28.0%
Rácio P/B
8.80
P/FCF
31.61
Margem Bruta
24.8%
ROIC
-
Radar de Rentabilidade
Value Creation (Economic Moat)
ROIC
-
WACC
10.3%
ROIC − WACC
-
Critérios de Análise Fundamental
Aprovado (14)
- EPS shows upward trend
- Price CAGR 19.12%
- Debt/Equity ratio
- Positive Free Cash Flow
- Current Ratio
- Debt/EBITDA
- Return on Tangible Assets
- Low reliance on intangibles
- ROE 29.9%
- Revenue Growth 5Y 11.6%
- Earnings Quality (OCF/NI) 1.31
- Share Dilution -0.8%
- Net Margin Trend 11.7% vs 11.0%
- Piotroski F-Score 7/9
Reprovado (7)
- EPS CAGR 0.24%
- Gross Margin 24.8%
- P/FCF 31.61
- P/B Ratio 8.80
- CapEx intensity
- Price below Graham Number
- DCF valuation (Overvalued)
Indisponível (7)
- ROIC NaN%
- Dividend Payout NaN%
- Operating Margin NaN%
- Interest Coverage
- Analyst Consensus (Finnhub)
- Earnings Surprise (no valid data)
- PEG Ratio (need PE > 0 and growth > 0)
Piotroski F-Score
Saúde financeira sólida
Qualidade dos Resultados
Alta qualidade: resultados respaldados por caixa
Diluição de Ações
A recomprar ações. Favorável ao acionista
Governação
Equipa Executiva
| Nome | Cargo | Idade |
|---|---|---|
| Mr. Michael G. Combs | Executive Chair | 61 |
| Mr. Brian S. Nichols | Chief Financial Officer | 44 |
| Ms. Jennifer L. Yoss | Vice President of Accounting | 47 |
| Mr. Maxim Shishin | Chief Information Officer | 50 |
| Mr. Mark E. Bertels | Executive Vice President of Risk Management Services | 62 |
| Ms. Sarah Scott | President & CEO | 48 |
| Ms. Sharon F. O'Connor | Vice President of Legal Services | - |
| Melissa Storan | Vice President of Marketing | - |
| Jason Wheeler | Vice President of Sales & Account Management | - |
| Mr. Jeffrey D. Gurtcheff | Chief Claims Officer | - |
Risco de Auditoria
4
Risco do Conselho
6
Risco de Remuneração
5
Risco dos Direitos dos Acionistas
7
Parte 2 · O preço e o momento de entrar
Esta parte não serve para saber se a empresa vale: serve para escolher quando comprá-la, depois que os fundamentos te convenceram. Dentro: análise técnica, potencial, quedas históricas, exposição gama.
Latest News
Recent headlines for CRVL, sourced from Markets Gazette.